Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

259 (8%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

3057 (92%)

3327

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

411 (94%)

Reversed:

23 (5%)

436

485 (13%)

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TRISENOX 1MG SOLUTION Resolved 2017-07-14 2018-07-30 15753
TRISENOX 10MG SOLUTION Actual shortage 2020-05-14 2022-06-03 115216
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-08-22 2019-10-10 92198
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2024-12-10 2025-04-24 245304
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-01-27 98185
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2020-03-12 2020-08-27 108601
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2020-11-06 2021-01-07 128028
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2025-07-03 2026-03-12 261785
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2025-01-30 2025-04-24 249198
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2024-12-20 2026-03-12 246267
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2020-02-21 2020-04-09 106925
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2025-08-14 2026-03-12 265143
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2020-08-06 2020-11-07 121865
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Avoided shortage 2021-08-23 2021-08-23 144448
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Avoided shortage 2021-08-23 2021-08-23 144451
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Avoided shortage 2021-08-23 2021-08-23 144454
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2021-08-24 2022-01-07 144494
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2021-08-24 2022-01-07 144497
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-28 2020-06-25 99955
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-02-21 98179

Showing 3301 to 3320 of 3327

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-FOSINOPRIL 20MG TABLET Discontinued 2025-05-28 2025-05-28 258640
TEVA-FUROSEMIDE 20MG TABLET Discontinued 2017-06-27 2017-06-27 14039
TEVA-FUROSEMIDE 40MG TABLET Discontinued 2017-06-27 2017-06-27 14042
TEVA-GLYBURIDE 2.5MG TABLET Discontinued 2025-05-28 2025-05-28 258547
TEVA-HALOPERIDOL 20MG TABLET Discontinued 2019-10-25 2019-10-26 97270
TEVA-HYDROCHLOROTHIAZIDE 50MG TABLET Discontinued 2025-05-28 2025-05-28 258383
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2020-02-13 2020-02-13 106158
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2018-10-19 2018-10-19 64993
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2018-10-19 2018-10-19 64970
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2020-02-13 2020-02-13 106161
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2018-10-19 2018-10-19 64975
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2018-10-19 2018-10-19 64983
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2020-02-13 2020-02-13 106167
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2020-02-13 2020-02-13 106164
TEVA-IRBESARTAN 300MG TABLET TABLET Discontinued 2025-06-17 2025-06-17 260546
TEVA-IRBESARTAN 150MG TABLET Discontinued 2025-06-17 2025-06-17 260527
TEVA-IRBESARTAN 75MG TABLET Discontinued 2024-04-01 2024-04-01 224049
TEVA-IRBESARTAN HCTZ 150MG 12.5MG TABLET Discontinued 2025-06-17 2025-06-17 260549
TEVA-IRBESARTAN HCTZ 300MG 25MG TABLET Discontinued 2024-06-28 2024-06-29 231580
TEVA-IRBESARTAN HCTZ 300MG 12.5MG TABLET Discontinued 2024-06-28 2024-06-29 231577